Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Benjamin Theurer maintains Ambev (NYSE:ABEV) with a Equal-Weight and lowers the price target from $3 to $2.5.
Explore Ambev SA's Q1 FY24 performance: despite a 1.2% net revenue dip, organic growth surged by 4.5%. Discover the factors...
Ambev (NYSE:ABEV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 perce...
Capital market investors often look for entry points, hidden gems, and value bets. Quality stocks trading at or around their 52...
February labor report shows mixed signals: increase in non-farm payrolls but higher unemployment rate and downward revisions. W...
Barclays analyst Benjamin Theurer downgrades Ambev (NYSE:ABEV) from Overweight to Equal-Weight and lowers the price target f...
Microplastics are small plastic fragments found everywhere and can cause harm to human health. Boiling and filtering tap water ...
